)
Shares of Aurobindo Pharma were trading higher by 5% at Rs 1,368 on the NSE after the company announced bonus shares in the ratio of 1:1 .i.e. one bonus equity share for every equity share held.
Meanwhile, the drug company reported 20% year-on-year drop in consolidated net profit to Rs 404 crore for the fourth quarter ended March 31, 2015 (Q4), as against a net profit of Rs 502 crore a year ago.
Total operating income, however, jumped by 36% to Rs 3,162 crore for the quarter, compared with Rs 2,330 crore for the same period a year ago.
EBIDTA or operating profit margins before foreign exchange gain/loss stood at 20.7% against 32% in the previous year quarter, Aurobindo Pharma said in a press release.
The stock opened at Rs 1,317 and touched a high of Rs 1,370 on the NSE. Till 0932 hours, a combined 616,512 shares changed hands on the counter on the NSE and BSE.
Meanwhile, the drug company reported 20% year-on-year drop in consolidated net profit to Rs 404 crore for the fourth quarter ended March 31, 2015 (Q4), as against a net profit of Rs 502 crore a year ago.
Total operating income, however, jumped by 36% to Rs 3,162 crore for the quarter, compared with Rs 2,330 crore for the same period a year ago.
EBIDTA or operating profit margins before foreign exchange gain/loss stood at 20.7% against 32% in the previous year quarter, Aurobindo Pharma said in a press release.
The stock opened at Rs 1,317 and touched a high of Rs 1,370 on the NSE. Till 0932 hours, a combined 616,512 shares changed hands on the counter on the NSE and BSE.
